Immune response of neonates to oral poliomyelitis vaccine.
نویسنده
چکیده
881 Immune response of neonates to oral poliomyelitis vaccine In the conventional schedule of immunisation infants are given three doses of oral poliomyelitis vaccine starting at, or after, 6 to 8 weeks of age. In the new pulse immunisation strategy three doses of oral poliomyelitis vaccine are given in annual cycles to children under 24 months of age.' I carried out a study to see whether a lower age limit could be established in this programme. Neonates were given one dose of oral poliomyelitis vaccine followed by second and third doses at intervals of four weeks. The seroconversion response in the neonates was as good as the response in older infants, indicating that immunisation may be started in the neonatal period. I studied 180 neonates and infants with parental consent. The first dose of oral poliomyelitis vaccine was given to groups of 30 infants at 7, 14, 21, 28, 35, and 42 days (one day) of age. Second and third doses were given at intervals of four weeks. The vaccine was tested and found to be fully potent. At least 30 minutes was allowed between administration of the vaccine and breast feeding. Capillary blood was collected immediately before giving the first dose of the vaccine and four weeks after the last dose. The second sample of blood was collected from only 139 infants. The paired serum samples were tested together in doubling dilutions from 1/8 to 1/1024 for poliovirus neutralising antibodies as described previously.2 The second serum sample was collected 12 weeks after the first. As the half life of maternal antibody in the infant's circulation is less than four weeks the persisting maternal antibody titre in the second serum sample would be lower than that in the first by a factor of eight or more. A fourfold or higher titre than the expected residual maternal antibody titre in the second serum sample was taken to indicate the infant's immune response (seroconversion) to the three doses of oral poliomyelitis vaccine.2 3 The table shows the frequency of the antibody response in the neonates and infants to three doses of poliomyelitis vaccine according to age at the start of immunisation. It also compares the antibody response of infants aged from 6 to 20 weeks with maternal antibody with that of infants aged from 6 to 51 weeks without maternal antibody from a previous study.2 The seroconversion response to the three types …
منابع مشابه
Early immunization of neonates with trivalent oral poliovirus vaccine.
Described is the evaluation in Brazil of the immune response of early immunization with trivalent oral poliovirus vaccine (TOPV). A total of 85 normal neonates from São Paulo were assigned one of the following immunization schedules: group A--one dose of TOPV at birth and subsequent doses at 2, 4, and 9 months of age; or group B--one dose of TOPV at 2, 4 and 6 months of age. Blood samples were ...
متن کاملStudy of Immune Response in Infants of Non-Gestational Diabetic Mothers
Background Infants of diabetic mothers (IDMs) have significantly greater risk for spontaneous abortion, stillbirth, congenital malformations and perinatal mortality and morbidity but whether maternal DM affects the neonatal innate immune system is unknown. We aimed to assess the immune response of infants of diabetic mothers (IDMs) with non-gestational DM for Hepatitis B vaccine and to compare ...
متن کاملInternational comparison of species of monkey used for the neurovirulence test for oral poliomyelitis vaccine
متن کامل
Poliomyelitis Vaccine
The Epidemiology of poliomgelitis has been investigated in our country Pasteur Institute; the incidence of Poliomgelitis, after the age of 4 years i's rare, in Iran. Passive antibody of maternal origin do not interfere with production of active antibody after immunization. Inactivated Polio Vaccine (salk) has been effective in reducing the incidence of poliomgelitis by approximately 90 per ...
متن کاملStability Study of Razi Trivalent and Monovalent Oral Poliomyelitis Vaccine
Stability studies play a critical role in assuring product quality at all points in the vaccine life cycle. These studies used to determine vaccine expiry date and vaccine efficacy. Accelerated stability and long term stability study performed for three batches of trivalent oral poliomyelitis vaccine (OPV) and three batches of monovalent OPV (type1) manufactured by Razi institute. After samplin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British medical journal
دوره 289 6449 شماره
صفحات -
تاریخ انتشار 1984